REVUMENIB

Clinical trials for REVUMENIB explained in plain language.

Never miss a new study

Get alerted when new REVUMENIB trials appear

Sign up with your email to follow new studies for REVUMENIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo tackles tough leukemia

Disease control Not yet recruiting

This early-phase study tests two drugs, blinatumomab and revumenib, given together to adults with a rare and aggressive form of acute lymphoblastic leukemia (ALL) that has a specific genetic change called KMT2A rearrangement. The main goal is to find a safe dose and understand si…

Matched conditions: REVUMENIB

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 16, 2026 12:54 UTC

REVUMENIB

Get alerted when new REVUMENIB trials appear

New combo tackles tough leukemia